Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study

Paola Mosconi, Anna Roberto, Nicoletta Cerana, Nicoletta Colombo, Florence Didier, Maurizio D’Incalci, Domenica Lorusso, Fedro Alessandro Peccatori, Grazia Artioli, Luigi Cavanna, Rita Ceccherini, Giovanna Cirigliano, Giovanni Cirigliano, Giuseppe Comerci, Gianluca Comerci, Gennaro Cormio, Alessandra Crippa, Alberto Farolfi, Antonio Febbraro, Donatella GiardinaStefano Greggi, Maurizio Lalle, Mariateresa Lapresa, Marina Marzola, Maria Cristina Marzola, Carla Merisio, Anna Maria Mosconi, Michele Peiretti, Giuseppe Ricci, Graziana Ronzino, Giovanni Scambia, Paolo Scollo, Federica Sina, Giulia Carlo Stella, Federica Tomao, Patrizia Vici, Paolo Zola

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Despite several initiatives by research groups, regulatory authorities, and scientific associations to engage citizens/patients in clinical research, there are still obstacles to participation. Among the main discouraging aspects are incomplete understanding of the concepts related to a clinical trial, and the scant, sometimes confused, explanations given. This observational, cross-sectional multicenter study investigated knowledge, attitudes and trust in clinical research. We conducted a survey among women with ovarian cancer at their first follow-up visit or first therapy session, treated in centers belonging to the Mario Negri Gynecologic Oncology (MaNGO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups. A questionnaire on knowledge, attitudes and experience was assembled ad hoc after a literature review and a validation process involving patients of the Alliance against Ovarian Cancer (ACTO).
Lingua originaleEnglish
pagine (da-a)1-9
Numero di pagine9
RivistaJournal of Ovarian Research
Volume15
DOI
Stato di pubblicazionePubblicato - 2022

Keywords

  • ACTO study
  • ovarian cancer

Fingerprint

Entra nei temi di ricerca di 'Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study'. Insieme formano una fingerprint unica.

Cita questo